{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:17:07Z","timestamp":1788175027070,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"New Technologies for Translational Research in Pharmaceutical Sciences\u201d (NETPHARM), project co-funded by the European Union","award":["CZ.02.01.01\/00\/22_008\/0004607"],"award-info":[{"award-number":["CZ.02.01.01\/00\/22_008\/0004607"]}]},{"name":"MH CZ - DRO","award":["00179906"],"award-info":[{"award-number":["00179906"]}]},{"name":"UNCE","award":["UNCE\/18\/SCI\/012"],"award-info":[{"award-number":["UNCE\/18\/SCI\/012"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Parasitic nematodes cause significant health issues in livestock, resulting in clinical complications and economic losses worldwide. As the efficacy of current anthelmintic drugs is being compromised by the emergence of drug resistance, a search for novel therapeutics with new modes of action is necessary. Obefazimod (ABX464) originally developed for human inflammatory diseases, has recently shown promising nematocidal activity against\n                    <jats:italic>Haemonchus contortus<\/jats:italic>\n                    and other parasitic nematodes. This study aimed to elucidate the biotransformation pathways of obefazimod in\n                    <jats:italic>H. contortus<\/jats:italic>\n                    and in its host, sheep. Adult nematodes (females and males separately) of drug-susceptible and drug-resistant strains and ovine liver models were used. Using a newly developed and optimized UHPLC-HRMS\/MS method, we identified 13 metabolites formed via phase I and II metabolism. These findings provide the first insight into the metabolic fate of obefazimod in target parasites and host species.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-49484-1","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T04:08:37Z","timestamp":1776830917000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Biotransformation of obefazimod, a novel potential anthelmintic, in sheep and the target nematode Haemonchus contortus"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8501-2868","authenticated-orcid":false,"given":"Luk\u00e1\u0161","family":"Lochman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9692-7641","authenticated-orcid":false,"given":"Martin","family":"Nov\u00e1k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0741-3871","authenticated-orcid":false,"given":"Lenka","family":"Sk\u00e1lov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2266-6105","authenticated-orcid":false,"given":"Gabriela","family":"Svobodov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3052-7965","authenticated-orcid":false,"given":"Radim","family":"Ku\u010dera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8476-1514","authenticated-orcid":false,"given":"Lucie","family":"Raisov\u00e1 Stuchl\u00edkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"49484_CR1","doi-asserted-by":"publisher","DOI":"10.1515\/opag-2022-0234","author":"N Nolinda","year":"2024","unstructured":"Nolinda, N., Ikusika, O. O., Akinmoladun, O. F. & Mpendulo, C. T. Impact of nematode infestation in livestock production and the role of natural feed additives\u2014A review. Open Agric. https:\/\/doi.org\/10.1515\/opag-2022-0234 (2024).","journal-title":"Open Agric."},{"key":"49484_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s11356-023-31045-y","author":"A Mukherjee","year":"2023","unstructured":"Mukherjee, A., Kar, I. & Patra, A. K. Understanding anthelmintic resistance in livestock using \u201comics\u201d approaches. Environ. Sci. Pollut. Res. Int. https:\/\/doi.org\/10.1007\/s11356-023-31045-y (2023).","journal-title":"Environ. Sci. Pollut. Res. Int."},{"key":"49484_CR3","doi-asserted-by":"publisher","first-page":"5403","DOI":"10.2147\/IDR.S332378","volume":"14","author":"W Fissiha","year":"2021","unstructured":"Fissiha, W. & Kinde, M. Z. Anthelmintic resistance and its mechanism: A review. Infect. Drug Resist. 14, 5403\u20135410. https:\/\/doi.org\/10.2147\/IDR.S332378 (2021).","journal-title":"Infect. Drug Resist."},{"key":"49484_CR4","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.pt.2018.05.005","volume":"34","author":"C Lanusse","year":"2018","unstructured":"Lanusse, C. et al. Strategies to optimize the efficacy of anthelmintic drugs in ruminants. Trends Parasitol. 34, 664\u2013682. https:\/\/doi.org\/10.1016\/j.pt.2018.05.005 (2018).","journal-title":"Trends Parasitol."},{"key":"49484_CR5","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.drudis.2019.12.007","volume":"25","author":"M Zaj\u00edckov\u00e1","year":"2020","unstructured":"Zaj\u00edckov\u00e1, M., Nguyen, L. T., Sk\u00e1lov\u00e1, L., Stuchl\u00edkov\u00e1, L. R. & Matouskov\u00e1, P. Anthelmintics in the future: Current trends in the discovery and development of new drugs against gastrointestinal nematodes. Drug Discov. Today. 25, 430\u2013437. https:\/\/doi.org\/10.1016\/j.drudis.2019.12.007 (2020).","journal-title":"Drug Discov. Today."},{"key":"49484_CR6","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ijpddr.2014.07.002","volume":"4","author":"G Panic","year":"2014","unstructured":"Panic, G., Duthaler, U., Speich, B. & Keiser, J. Repurposing drugs for the treatment and control of helminth infections. Int. J. Parasitol. Drugs Drug Resist. 4, 185\u2013200. https:\/\/doi.org\/10.1016\/j.ijpddr.2014.07.002 (2014).","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"49484_CR7","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1093\/infdis\/jiad251","volume":"228","author":"S Bernal","year":"2023","unstructured":"Bernal, S. et al. Impact of Obefazimod on viral persistence, inflammation, and immune activation in people with Human Immunodeficiency Virus on suppressive antiretroviral therapy. J. Infect. Dis. 228, 1280\u20131291. https:\/\/doi.org\/10.1093\/infdis\/jiad251 (2023).","journal-title":"J. Infect. Dis."},{"key":"49484_CR8","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/s2468-1253(22)00233-3","volume":"7","author":"S Vermeire","year":"2022","unstructured":"Vermeire, S. et al. ABX464 (Obefazimod) for moderate-to-severe, active ulcerative colitis: A phase 2b, double-blind, randomised, placebo-controlled induction trial and 48 week, open-label extension. Lancet Gastroenterol. Hepatol. 7, 1024\u20131035. https:\/\/doi.org\/10.1016\/s2468-1253(22)00233-3 (2022).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"49484_CR9","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1093\/ecco-jcc\/jjad067","volume":"17","author":"S Vermeire","year":"2023","unstructured":"Vermeire, S. et al. Obefazimod: A first-in-class drug for the treatment of ulcerative colitis. J. Crohns Colitis. 17, 1689\u20131697. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjad067 (2023).","journal-title":"J. Crohns Colitis."},{"key":"49484_CR10","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1136\/annrheumdis-2022-222228","volume":"81","author":"C Daien","year":"2022","unstructured":"Daien, C. et al. Safety and efficacy of the miR-124 upregulator ABX464 (Obefazimod, 50 and 100 mg per day) in patients with active rheumatoid arthritis and inadequate response to methotrexate and\/or anti-TNF\u03b1 therapy: A placebo-controlled phase II study. Ann. Rheum. Dis. 81, 1076\u20131084. https:\/\/doi.org\/10.1136\/annrheumdis-2022-222228 (2022).","journal-title":"Ann. Rheum. Dis."},{"key":"49484_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpddr.2024.100522","author":"HT Shanley","year":"2024","unstructured":"Shanley, H. T. et al. Structure-activity relationship and target investigation of 2-aryl quinolines with nematocidal activity. Int. J. Parasitol. Drugs Drug Resist. https:\/\/doi.org\/10.1016\/j.ijpddr.2024.100522 (2024).","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"49484_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2023.117540","author":"HT Shanley","year":"2024","unstructured":"Shanley, H. T. et al. Structure activity relationship and target prediction for ABX464 analogues in Caenorhabditis elegans. Bioorg. Med. Chem. https:\/\/doi.org\/10.1016\/j.bmc.2023.117540 (2024).","journal-title":"Bioorg. Med. Chem."},{"key":"49484_CR13","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3390\/ph15020257","volume":"15","author":"HT Shanley","year":"2022","unstructured":"Shanley, H. T. et al. A high-throughput phenotypic screen of the \u2018Pandemic Response Box\u2019 identifies a quinoline derivative with significant anthelmintic activity. Pharmaceuticals 15, 257 (2022).","journal-title":"Pharmaceuticals"},{"key":"49484_CR14","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000560","author":"C Apolit","year":"2023","unstructured":"Apolit, C. et al. ABX464 (Obefazimod) upregulates miR-124 to reduce proinflammatorymarkers in inflammatory bowel diseases. Clin. Transl. Gastroenterol. https:\/\/doi.org\/10.14309\/ctg.0000000000000560 (2023).","journal-title":"Clin. Transl. Gastroenterol."},{"key":"49484_CR15","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1093\/jac\/dkw458","volume":"72","author":"D Scherrer","year":"2017","unstructured":"Scherrer, D. et al. Pharmacokinetics and tolerability of ABX464, a novel first-in-class compound to treat HIV infection, in healthy HIV-uninfected subjects. J. Antimicrob. Chemother. 72, 820\u2013828. https:\/\/doi.org\/10.1093\/jac\/dkw458 (2017).","journal-title":"J. Antimicrob. Chemother."},{"key":"49484_CR16","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.trac.2014.08.006","volume":"63","author":"L Zhao","year":"2014","unstructured":"Zhao, L. & Li, F. UHPLC-MS strategies and applications for bioanalyses related to pharmacokinetics and drug metabolism. TrAC Trends Anal. Chem. 63, 170\u2013179. https:\/\/doi.org\/10.1016\/j.trac.2014.08.006 (2014).","journal-title":"TrAC Trends Anal. Chem."},{"key":"49484_CR17","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.trac.2014.06.025","volume":"63","author":"A Kaufmann","year":"2014","unstructured":"Kaufmann, A. Combining UHPLC and high-resolution MS: A viable approach for the analysis of complex samples?. TrAC Trends Anal. Chem. 63, 113\u2013128. https:\/\/doi.org\/10.1016\/j.trac.2014.06.025 (2014).","journal-title":"TrAC Trends Anal. Chem."},{"key":"49484_CR18","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ipara.2003.10.002","volume":"34","author":"MH Roos","year":"2004","unstructured":"Roos, M. H., Otsen, M., Hoekstra, R., Veenstra, J. G. & Lenstra, J. A. Genetic analysis of inbreeding of two strains of the parasitic nematode Haemonchus contortus. Int. J. Parasitol. 34, 109\u2013115. https:\/\/doi.org\/10.1016\/j.ipara.2003.10.002 (2004).","journal-title":"Int. J. Parasitol."},{"key":"49484_CR19","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.ijpddr.2017.10.001","volume":"7","author":"E Yilmaz","year":"2017","unstructured":"Yilmaz, E., Ram\u00fcnke, S., Demeler, J. & Kr\u00fccken, J. Comparison of constitutive and thiabendazole-induced expression of five cytochrome P450 genes in fourth-stage larvae of Haemonchus contortus isolates with different drug susceptibility identifies one gene with high constitutive expression in a multi-resistant isolate. Int. J. Parasitol. Drugs Drug Resist. 7, 362\u2013369. https:\/\/doi.org\/10.1016\/j.ijpddr.2017.10.001 (2017).","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"49484_CR20","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.1365-2885.2004.00557.x","volume":"27","author":"V Baliharov\u00e1","year":"2004","unstructured":"Baliharov\u00e1, V. et al. The effects of fenbendazole, flubendazole and mebendazole on activities of hepatic cytochromes P450 in pig. J. Vet. Pharmacol. Ther. 27, 85\u201390. https:\/\/doi.org\/10.1111\/j.1365-2885.2004.00557.x (2004).","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"49484_CR21","first-page":"147","volume":"47","author":"JA van Wyk","year":"1980","unstructured":"van Wyk, J. A., Gerber, H. M. & Groeneveld, H. T. A technique for the recovery of nematodes from ruminants by migration from gastro-intestinal ingesta gelled in agar: Large-scale application. Onderstepoort J. Vet. Res. 47, 147\u2013158 (1980).","journal-title":"Onderstepoort J. Vet. Res."},{"key":"49484_CR22","unstructured":"XCalibur Software ver. 4.3.73.11. https:\/\/knowledge1.thermofisher.com\/Software_and_Downloads\/Chromatography_and_Mass_Spectrometry_Software\/Xcalibur\/Xcalibur_Software_and_Release_Notes\/XCALI-98088_-_Xcalibur_4.3_Release_Notes."},{"key":"49484_CR23","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.jchromb.2009.02.006","volume":"877","author":"EM Hodel","year":"2009","unstructured":"Hodel, E. M. et al. A single LC-tandem mass spectrometry method for the simultaneous determination of 14 antimalarial drugs and their metabolites in human plasma. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877, 867\u2013886. https:\/\/doi.org\/10.1016\/j.jchromb.2009.02.006 (2009).","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"49484_CR24","volume-title":"Casarett and Doull\u2019s Toxicology: The Basic Science of Poisons","author":"A Parkinson","year":"2012","unstructured":"Parkinson, A. et al. Casarett and Doull\u2019s Toxicology: The Basic Science of Poisons 8th edn. (McGraw-Hill Education, 2012).","edition":"8"},{"key":"49484_CR25","doi-asserted-by":"publisher","first-page":"561","DOI":"10.2174\/1389200023337054","volume":"3","author":"PB Danielson","year":"2002","unstructured":"Danielson, P. B. The cytochrome P450 superfamily: Biochemistry, evolution and drug metabolism in humans. Curr. Drug Metab. 3, 561\u2013597. https:\/\/doi.org\/10.2174\/1389200023337054 (2002).","journal-title":"Curr. Drug Metab."},{"key":"49484_CR26","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1006\/abbi.2001.2568","volume":"395","author":"R Menzel","year":"2001","unstructured":"Menzel, R., Bogaert, T. & Achazi, R. A systematic gene expression screen of Caenorhabditis elegans cytochrome P450 genes reveals CYP35 as strongly xenobiotic inducible. Arch. Biochem. Biophys. 395, 158\u2013168. https:\/\/doi.org\/10.1006\/abbi.2001.2568 (2001).","journal-title":"Arch. Biochem. Biophys."},{"key":"49484_CR27","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1097\/00000542-199310000-00023","volume":"79","author":"ED Kharasch","year":"1993","unstructured":"Kharasch, E. D. & Thummel, K. E. Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane, and methoxyflurane. Anesthesiology 79, 795\u2013807. https:\/\/doi.org\/10.1097\/00000542-199310000-00023 (1993).","journal-title":"Anesthesiology"},{"key":"49484_CR28","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1021\/cr9002193","volume":"110","author":"PR Ortiz de Montellano","year":"2010","unstructured":"Ortiz de Montellano, P. R. Hydrocarbon hydroxylation by cytochrome P450 enzymes. Chem. Rev. 110, 932\u2013948. https:\/\/doi.org\/10.1021\/cr9002193 (2010).","journal-title":"Chem. Rev."},{"key":"49484_CR29","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.pt.2017.02.004","volume":"33","author":"R Laing","year":"2017","unstructured":"Laing, R., Gillan, V. & Devaney, E. Ivermectin - Old drug, New tricks?. Trends Parasitol 33, 463\u2013472. https:\/\/doi.org\/10.1016\/j.pt.2017.02.004 (2017).","journal-title":"Trends Parasitol"},{"key":"49484_CR30","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.pt.2016.02.004","volume":"32","author":"P Matouskova","year":"2016","unstructured":"Matouskova, P., Vokral, I., Lamka, J. & Skalova, L. The role of xenobiotic-metabolizing enzymes in anthelmintic deactivation and resistance in helminths. Trends Parasitol 32, 481\u2013491. https:\/\/doi.org\/10.1016\/j.pt.2016.02.004 (2016).","journal-title":"Trends Parasitol"},{"key":"49484_CR31","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.ijpara.2005.01.012","volume":"35","author":"PM Jones","year":"2005","unstructured":"Jones, P. M. & George, A. M. Multidrug resistance in parasites: ABC transporters, P-glycoproteins and molecular modelling. Int. J. Parasitol. 35, 555\u2013566. https:\/\/doi.org\/10.1016\/j.ijpara.2005.01.012 (2005).","journal-title":"Int. J. Parasitol."},{"key":"49484_CR32","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1124\/mol.109.056705","volume":"76","author":"DJ Waxman","year":"2009","unstructured":"Waxman, D. J. & Holloway, M. G. Sex differences in the expression of hepatic drug metabolizing enzymes. Mol. Pharmacol. 76, 215\u2013228. https:\/\/doi.org\/10.1124\/mol.109.056705 (2009).","journal-title":"Mol. Pharmacol."},{"key":"49484_CR33","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00216-008-1962-7","volume":"391","author":"M Holcapek","year":"2008","unstructured":"Holcapek, M., Kolarova, L. & Nobilis, M. High-performance liquid chromatography-tandem mass spectrometry in the identification and determination of phase I and phase II drug metabolites. Anal. Bioanal. Chem. 391, 59\u201378. https:\/\/doi.org\/10.1007\/s00216-008-1962-7 (2008).","journal-title":"Anal. Bioanal. Chem."},{"key":"49484_CR34","doi-asserted-by":"publisher","first-page":"3908","DOI":"10.1016\/j.chroma.2010.02.049","volume":"1217","author":"M Holcapek","year":"2010","unstructured":"Holcapek, M., Jir\u00e1sko, R. & L\u00edsa, M. Basic rules for the interpretation of atmospheric pressure ionization mass spectra of small molecules. J. Chromatogr. A 1217, 3908\u20133921. https:\/\/doi.org\/10.1016\/j.chroma.2010.02.049 (2010).","journal-title":"J. Chromatogr. A"},{"key":"49484_CR35","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1111\/j.1365-2885.2010.01177.x","volume":"33","author":"L Mat\u00e9","year":"2010","unstructured":"Mat\u00e9, L. et al. Phase 1 and phase 2 metabolic activities along the small intestine in adult male sheep. J. Vet. Pharmacol. Ther. 33, 537\u2013545. https:\/\/doi.org\/10.1111\/j.1365-2885.2010.01177.x (2010).","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"49484_CR36","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.ijpara.2014.12.001","volume":"45","author":"R Laing","year":"2015","unstructured":"Laing, R. et al. The cytochrome P450 family in the parasitic nematode Haemonchus contortus. Int. J. Parasitol. 45, 243\u2013251. https:\/\/doi.org\/10.1016\/j.ijpara.2014.12.001 (2015).","journal-title":"Int. J. Parasitol."},{"key":"49484_CR37","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.ijpddr.2018.09.005","volume":"8","author":"P Matou\u0161kov\u00e1","year":"2018","unstructured":"Matou\u0161kov\u00e1, P. et al. UDP-glycosyltransferase family in Haemonchus contortus: Phylogenetic analysis, constitutive expression, sex-differences and resistance-related differences. Int. J. Parasitol. Drugs Drug Resist. 8, 420\u2013429. https:\/\/doi.org\/10.1016\/j.ijpddr.2018.09.005 (2018).","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"49484_CR38","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1152\/physrev.00058.2017","volume":"99","author":"R Meech","year":"2019","unstructured":"Meech, R. et al. The UDP-glycosyltransferase (UGT) superfamily: New members, new functions, and novel paradigms. Physiol. Rev. 99, 1153\u20131222. https:\/\/doi.org\/10.1152\/physrev.00058.2017 (2019).","journal-title":"Physiol. Rev."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49484-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49484-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49484-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T10:42:17Z","timestamp":1788172937000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49484-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["49484"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-49484-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"assertion":[{"value":"16 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this Article was revised: In the original version of this Article, the names of all authors were incorrectly indexed. The original Article has been corrected.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations by the Ethics Committee of the Ministry of Education, Youth and Sports of the Czech Republic (Protocol MSMT-20144\/2023-4).","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors consent to the publication of this article, including any images or recordings, and have approved the content.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"18620"}}